Indian Ciprofloxacin Exporters: Complete Supplier Ranking with Market Share — 3081 Manufacturers (2026) — TransData Nexus

Q: Who is the largest ciprofloxacin buyer importing from India?

DR REDDYS LABORATORIES INC (UNITED STATES) is the largest ciprofloxacin importer from India with a 10.3% market share and import value of $30.9M.

Q: How many ciprofloxacin buyers import from India?

There are 3081 active ciprofloxacin buyers importing from India, with a combined import market of $301.1M across 14,146 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top ciprofloxacin buyers from India?

The top 5 ciprofloxacin buyers — DR REDDYS LABORATORIES INC, DR, REDDYS LABORATORIES, INC, NORTHSTAR DISTRIBUTION CENTRE 8912, DELTA IMPORT - EXPORT MEDICAL CO,, DR.REDDY'S LABORATORIES,INC — together control 29.9% of total ciprofloxacin import value from India.

Suresh Sormare

Ciprofloxacin

India Pharmaceutical Trade Intelligence

$301.1M1,001 Suppliers180 CountriesHS 30042013

ExportsIndia → UNITED STATES42.3%India → RUSSIA7.1%

ImportsUNITED STATES → India$518.1K ITALY → India$94.7K

#1 Buyer: DR REDDYS

Market Analysis: Top Importing Countries & Their Importers

1United States

United States emerges as the first largest importing country, achieving a total trade value of $127.3M through 264 shipments. This represents a market share of 42.3% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: United States has a diverse importer base, with their top importers including:

• DR REDDYS LABORATORIES INC - $30.9M (24.3% of country's total business)

• DR, REDDYS LABORATORIES, INC - $23.4M (18.4% of country's total business)

• NORTHSTAR DISTRIBUTION CENTRE 8912 - $13.4M (10.5% of country's total business)

• DR.REDDY'S LABORATORIES,INC - $10.5M (8.2% of country's total business)

• SUN PHARMACEUTICAL INDUSTRIES,INC. - $9.3M (7.3% of country's total business)

• Rest of United States's importers - $39.8M (31.3% of country's total business)

Key Insight: United States demonstrates strong market positioning with an average shipment value of $482.2K, indicating premium pricing strategy compared to the market average of $21.3K.

United States is a key market for Ciprofloxacin imports, representing 42.3% of total trade value.

Primary Market

Secondary Market

Buyer Segment Analysis

TransData Nexus Ciprofloxacin buyer market intelligence

1Buyer Segment Analysis

The importers of Ciprofloxacin from India can be categorized into several key segments:

1. Pharmaceutical Companies: Entities such as Dr. Reddy's Laboratories Inc. and Sun Pharmaceutical Industries Inc. in the United States fall into this category. These companies import Ciprofloxacin for direct distribution and sale under their brand names. Their purchasing behavior is characterized by large, consistent orders to maintain a steady supply chain and meet market demand.

2. Distributors: Companies like Northstar Distribution Centre 8912 in the United States serve as intermediaries, purchasing Ciprofloxacin in bulk and supplying it to various healthcare providers, pharmacies, and retailers. Their order patterns are typically large and regular, aligning with the needs of their diverse client base.

3. Government Procurement Agencies: Entities such as Delta Import - Export Medical Co. in Vietnam and Fidson Healthcare Plc in Nigeria often participate in government tenders to supply Ciprofloxacin to public health facilities. Their purchasing behavior is influenced by government procurement cycles, leading to large, periodic orders based on tender awards.

4. Hospital Groups and Healthcare Providers: Organizations like AO Ranbaxy and LLC Sentiss Rus in Russia may represent hospital groups or large healthcare providers that import Ciprofloxacin directly for use within their facilities. Their order patterns are typically based on internal consumption rates, resulting in moderate to large orders placed at regular intervals.

5. Contract Manufacturers: Some buyers may act as contract manufacturers, importing Ciprofloxacin as an active pharmaceutical ingredient (API) for the production of finished dosage forms. Their purchasing behavior is driven by production schedules and client demands, leading to variable order sizes and frequencies.

Country-Specific Import Regulations

TransData Nexus Ciprofloxacin buyer market intelligence

1Country-Specific Import Regulations

Understanding the import regulations for Ciprofloxacin in the top five importing countries is crucial for market entry and compliance:

1. United States:

Regulatory Authority: Food and Drug Administration (FDA).

Import Registration Process: Importers must ensure that Ciprofloxacin products are FDA-approved. The process involves submitting an Abbreviated New Drug Application (ANDA) for generic drugs, demonstrating bioequivalence to the brand-name counterpart.

Estimated Timeline: The ANDA review process typically takes 10 months, but this can vary based on the completeness of the application and FDA workload.

Import Tariff/Duty: Pharmaceutical products under HS Code 30042013 are generally duty-free in the United States.

2. Russia:

Regulatory Authority: Ministry of Health of the Russian Federation.

Demand Drivers & Market Opportunity

TransData Nexus Ciprofloxacin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Ciprofloxacin in importing countries is driven by several factors:

1. Disease Prevalence: Ciprofloxacin is a broad-spectrum antibiotic used to treat various bacterial infections, including respiratory tract infections, urinary tract infections, and gastrointestinal infections. High prevalence rates of these conditions in many countries contribute to sustained demand.

2. Government Healthcare Programs: Many countries have implemented healthcare programs aimed at improving access to essential medicines. For instance, the inclusion of Ciprofloxacin in national essential medicines lists ensures its availability in public health facilities.

3. Universal Health Coverage Expansion: Efforts to achieve universal health coverage have led to increased procurement of essential medicines like Ciprofloxacin to meet the healthcare needs of the population.

4. WHO Essential Medicines List Procurement: Ciprofloxacin's inclusion in the World Health Organization's Essential Medicines List underscores its importance in treating priority health conditions, prompting countries to prioritize its procurement.

5. Tender-Based Purchasing: Many governments and international organizations utilize tendering processes to procure medicines, ensuring competitive pricing and consistent supply. This approach is common in countries like Nigeria and Vietnam, where government tenders significantly influence procurement patterns.

With 3,081 buyers across 180 countries, the global market for Ciprofloxacin presents substantial opportunities. Understanding the specific demand drivers and regulatory landscapes in each country is essential for strategic market entry and sustained growth.

Common Questions — Ciprofloxacin Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest ciprofloxacin buyer importing from India?

Based on import volume and value, DR REDDYS LABORATORIES INC (UNITED STATES) leads with $30.9M in imports and a 10.3% market share — the highest of any single ciprofloxacin importer. DR, REDDYS LABORATORIES, INC (UNITED STATES) and NORTHSTAR DISTRIBUTION CENTRE 8912 (UNITED STATES) are the next largest buyers.

QHow many companies buy ciprofloxacin from India?

There are 3081 active ciprofloxacin buyers importing from India, with a combined market of $301.1M across 14,146 shipments to 180 countries. The top 5 buyers hold 29.9% of total import value, while the remaining 3076 buyers handle the other 70.1%.

QWhich countries import the most ciprofloxacin from India?

The top importing countries for ciprofloxacin from India are United States (42.3%), Russia (7.1%), Vietnam (6.9%), Nigeria (6.1%), Ethiopia (2.2%). These markets represent the largest demand centres for Indian pharmaceutical exports of ciprofloxacin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for ciprofloxacin from India?

The average import transaction value for ciprofloxacin from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Ciprofloxacin buyer market intelligence

1Buyer Segment Analysis

The importers of Ciprofloxacin from India can be categorized into several key segments:

Country-Specific Import Regulations

TransData Nexus Ciprofloxacin buyer market intelligence

1Country-Specific Import Regulations

Understanding the import regulations for Ciprofloxacin in the top five importing countries is crucial for market entry and compliance:

1. United States:

Regulatory Authority: Food and Drug Administration (FDA).

Estimated Timeline: The ANDA review process typically takes 10 months, but this can vary based on the completeness of the application and FDA workload.

Import Tariff/Duty: Pharmaceutical products under HS Code 30042013 are generally duty-free in the United States.

2. Russia:

Regulatory Authority: Ministry of Health of the Russian Federation.

Demand Drivers & Market Opportunity

TransData Nexus Ciprofloxacin buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Ciprofloxacin in importing countries is driven by several factors:

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Ciprofloxacin

Ciprofloxacin

Who Buys Ciprofloxacin from India — 3081 Importers Behind a $301.1M Market

Top Ciprofloxacin Importers — Ranked by Import Value

Top Ciprofloxacin Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Ciprofloxacin — and from which countries?

Ciprofloxacin — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1United States

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Ciprofloxacin Buyers & Importers

QWho is the largest ciprofloxacin buyer importing from India?

QHow many companies buy ciprofloxacin from India?

QWhich countries import the most ciprofloxacin from India?

QWhat is the average import order value for ciprofloxacin from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

2Russia

3Vietnam

4Nigeria

5Ethiopia

Analysis Methodology